Adial Pharmaceuticals Inc (ADIL)
1.70
-0.03
(-1.73%)
USD |
NASDAQ |
Apr 26, 11:52
Adial Pharmaceuticals Total Liabilities (Quarterly): 0.6531M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.6531M |
| September 30, 2023 | 0.5282M |
| June 30, 2023 | 0.4618M |
| March 31, 2023 | 2.462M |
| December 31, 2022 | 2.456M |
| September 30, 2022 | 2.333M |
| June 30, 2022 | 2.962M |
| March 31, 2022 | 3.256M |
| December 31, 2021 | 3.967M |
| September 30, 2021 | 3.246M |
| June 30, 2021 | 3.234M |
| March 31, 2021 | 3.008M |
| December 31, 2020 | 1.505M |
| September 30, 2020 | 1.093M |
| Date | Value |
|---|---|
| June 30, 2020 | 0.6819M |
| March 31, 2020 | 0.3898M |
| December 31, 2019 | 0.5391M |
| September 30, 2019 | 0.7769M |
| June 30, 2019 | 0.6266M |
| March 31, 2019 | 0.3292M |
| December 31, 2018 | 0.258M |
| September 30, 2018 | 0.3228M |
| June 30, 2018 | 1.481M |
| March 31, 2018 | 1.388M |
| December 31, 2017 | 1.032M |
| September 30, 2017 | 0.743M |
| June 30, 2017 | 0.6612M |
| December 31, 2016 | 0.255M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
0.3898M
Minimum
Mar 2020
3.967M
Maximum
Dec 2021
1.799M
Average
1.505M
Median
Dec 2020
Total Liabilities (Quarterly) Benchmarks
| BioVie Inc | 14.00M |
| BioSig Technologies Inc | 4.685M |
| Precision BioSciences Inc | 140.92M |
| Humacyte Inc | 114.68M |
| Monogram Orthopaedics Inc | 3.182M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 4.737M |
| Shareholders Equity (Quarterly) | 4.084M |